GEN Exclusives

More »

GEN News Highlights

More »
Oct 29, 2008

AMRI Adds Non-GMP Manufacturing Services with Expansion of India Facility

  • AMRI reports that is has expanded the multipurpose pilot plants in Aurangabad, India, providing non-GMP manufacturing services up to a 1,000-liters scale.

    The move increases AMRI’s ability to provide customized pilot-scale materials for customers. In addition to being a stand-alone provider, the new facility will serve as an extension to AMRI's kilo-lab capabilities in Hyderabad, India, which operates to 100 liters in scale.

    Certain plant production will be dedicated to making starting materials for AMRI's U.S. manufacturing facilities, significantly diminishing that plant’s reliance on external resource providers, the firm notes.

    “We look forward to realizing cost savings at our U.S. manufacturing operations by becoming our own provider for some raw materials, eliminating third-party costs in both money and lead time,” says chairman, CEO, and president, Thomas E. D’Ambra, Ph.D.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

The Triple Package and Success

One theory for explaining “success," put forward by Amy Chua Jed Rubenfeld, posits cultural traits such as a superiority complex, personal insecurity and impulse control. Union College professors Joshua Hart and Christopher Chabris counter that intelligence, conscientiousness, and economic advantage are the most likely elements of success, regardless of ethnicity. Do you think that Hart-Chabris make a better argument for achieving success than the Chua-Rubenfeld theory?

More »